Ligand validation:6EN6

XPE: 3,6,9,12,15,18,21,24,27-NONAOXANONACOSANE-1,29-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EN6_XPE_C_721	53%	70%	0.121	0.88	0.56	0.59	-	-	2	0	100%	1
6EN6_XPE_B_731	27%	63%	0.154	0.798	0.65	0.76	-	-	0	0	100%	1
8QFX_XPE_A_706	74%	73%	0.094	0.924	0.52	0.52	-	-	4	0	100%	1
6TT4_XPE_A_711	65%	76%	0.102	0.904	0.54	0.42	-	-	1	0	100%	1
6EN5_XPE_D_724	49%	73%	0.106	0.85	0.54	0.52	-	-	0	0	100%	1
6QS1_XPE_A_710	37%	67%	0.144	0.838	0.59	0.67	-	-	3	0	100%	0.93
6H5X_XPE_A_711	32%	76%	0.138	0.812	0.56	0.38	-	-	1	0	100%	1
5A0C_XPE_A_1003	100%	6%	0.033	0.989	2.58	2.37	10	7	1	0	97%	0.9677
5TVY_XPE_B_201	76%	75%	0.107	0.96	0.53	0.45	-	-	0	0	90%	0.9032
2CZL_XPE_A_501	69%	76%	0.102	0.916	0.55	0.41	-	-	1	0	100%	1
4ZFJ_XPE_K_302	61%	78%	0.102	0.931	0.66	0.25	-	-	0	0	77%	0.7742

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.